Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial

Abstract

Although benralizumab resulted in near-complete depletion of blood eosinophils, there was no clinical benefit over placebo.